×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
MECHANISM OF ACTION - THE LEADING PARADIGM
Session Chair(s)
Henk van den Berg, DrMed, PhD
Member Paediatric Committee
Medicines Evaluation Board, Netherlands
Max Wegner, PharmD, RPh
Head Regulatory Affairs
Bayer AG, Germany
Mechanism of Action- The leading line
Speaker(s)
Mechanism of Action- The leading line
Daniel Brasseur, DrMed
Federal Agency for Medicines Health Products (FAMHP), Belgium
PDCO Chairman
Model PIPs in Oncology- The way forward?
Henk van den Berg, DrMed, PhD
Medicines Evaluation Board, Netherlands
Member Paediatric Committee
Clinical Development in Oncology – How to draft the PIP?
Raphaël Rousseau, MD, PhD
Gritstone Oncology, Inc., United States
Executive Vice President and Chief Medical Officer
Have an account?